Hsiu-Wen Liu

Title: Hsiu-Wen Liu: Innovator in Optically Active Compounds

Introduction

Hsiu-Wen Liu is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of chemistry, particularly in the development of novel optically active compounds. Her work has implications for therapeutic applications, showcasing her innovative spirit and dedication to scientific advancement.

Latest Patents

Hsiu-Wen Liu holds a patent for "Optically active 2,3-dihydroimidazo(1,2-C) quinazoline derivatives." This invention relates to novel optically active 3-substituted methyl-5-methylthio-2,3-dihydroimidazo(1,2-C) quinazoline and 3-substituted methyl-2,3-dihydroimidazo(1,2-C) quinazolin-5(6H)-one. The patent outlines the therapeutical use of these compounds, which can include various substituents such as halogen, hydrogen, methoxy, trifluoromethyl, C1-C4 alkyl, nitro, acetyl, cyano, or hydroxy groups, as well as their pharmaceutically acceptable salts.

Career Highlights

Hsiu-Wen Liu is affiliated with the National Science Council, where she continues to engage in research and development. Her work has led to advancements in the understanding and application of optically active compounds in medicinal chemistry.

Collaborations

Hsiu-Wen Liu has collaborated with notable colleagues, including Ji-Wang Chern and Alexander Gutcait. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful scientific discoveries.

Conclusion

Hsiu-Wen Liu's contributions to the field of chemistry, particularly through her patent on optically active compounds, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also has the potential to improve therapeutic applications in medicine.